Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Expected Frequencies in Goodness-of-Fit Tests01:19

Expected Frequencies in Goodness-of-Fit Tests

A goodness-of-fit test is conducted to determine whether the observed frequency values are statistically similar to the frequencies expected for the dataset. Suppose the expected frequencies for a dataset are equal such as when predicting the frequency of any number appearing when casting a die. In that case, the expected frequency is the ratio of the total number of observations (n) to the number of categories (k).
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular-Kidney-Metabolic Syndrome: Conceptualising an Approach to Health Economic Modelling.

Diabetes, obesity & metabolism·2026
Same author

PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data.

Health technology assessment (Winchester, England)·2026
Same author

Validation and Clinical Analysis of the Quantitative COPD Exacerbation Recognition Tool (Q-CERT): Diagnostic Performance and Association with Lung Function Impairment.

International journal of chronic obstructive pulmonary disease·2026
Same author

A dose-finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti-gremlin-1 monoclonal antibody, in patients with solid tumours.

British journal of clinical pharmacology·2026
Same author

Rapid isometric hamstring strength scores from professional soccer players at pre-season: Positional differences and relationship to peak force.

PloS one·2026
Same author

COPD Exacerbation Recognition Tool: Translation, Linguistic, and Cross-Cultural Validation.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same journal

Are preference-weighted cancer-specific measures more sensitive than generic measures? A comparison of EQ-5D-5L, SF-6Dv2, FACT-8D and QLU-C10D in gastrointestinal cancers.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Development and Validation of a Brief Healthcare Insecurity Scale in a Sample of U.S. Adults Living with and without HIV.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

A Competency Framework for Health Technology Assessment Expertise: Results from a Delphi Study.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Physician-led Switching from Reference Biologics to Biosimilars: What is the Effect on selected Health-Related Outcomes and Costs for IBD Patients in Germany?

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Critical Comments by the European Medicines Agency on Patient-Reported Outcomes in Regulatory Submissions (2020-2023).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Predicting EQ-5D values using the SGRQ.

Helen J Starkie1, Andrew H Briggs, Mike G Chambers

  • 1National Institute for Health and Clinical Excellence, London, UK. Helen.Starkie@nice.org.uk

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|March 16, 2011
PubMed
Summary
This summary is machine-generated.

A new algorithm accurately predicts EQ-5D utility from the St. George's Respiratory Questionnaire (SGRQ) in COPD patients. This tool aids in estimating quality-adjusted life-years (QALYs) but direct utility scores are preferred for health technology assessments.

More Related Videos

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
10:39

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning

Published on: August 29, 2025

Related Experiment Videos

Last Updated: Jun 3, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning
10:39

Qualitative and Quantitative Validation of Tools with Rating Scales Aimed at Assessing the Quality of University Service-Learning

Published on: August 29, 2025

Area of Science:

  • Pulmonary Medicine
  • Health Economics
  • Biostatistics

Background:

  • Chronic obstructive pulmonary disease (COPD) management requires accurate health outcome measurement.
  • The EQ-5D and St. George's Respiratory Questionnaire (SGRQ) are key instruments for assessing patient quality of life.
  • Bridging utility data between these instruments is crucial for health technology assessment (HTA).

Purpose of the Study:

  • To develop and validate an algorithm predicting EQ-5D utility scores from SGRQ data in COPD patients.
  • To assess the impact of this algorithm on quality-adjusted life-year (QALY) estimations.
  • To compare algorithm-derived QALYs with those directly measured by EQ-5D.

Main Methods:

  • Utilized data from the TORCH (Towards a Revolution in COPD Health) trial.
  • Employed ordinary least squares (OLS), generalized linear models (GLMs), and two-part models to map EQ-5D utility from SGRQ.
  • Validated algorithms using a separate sample, selecting the best model based on root-mean-square error (RMSE).

Main Results:

  • A straightforward OLS algorithm demonstrated performance comparable to more complex models.
  • The developed algorithm was: EQ-5D = 0.9617 - 0.0013 × SGRQ total - 0.0001 × SGRQ total(2) + 0.0231 × male (RMSE 0.1723).
  • The method used for utility estimation influenced the ordering of treatments based on QALY gain.

Conclusions:

  • A mapping algorithm can predict EQ-5D utility from SGRQ, offering utility in specific contexts.
  • For precise estimations in health technology assessments (HTA), direct derivation of utility scores from clinical trial populations is recommended.
  • Direct utility data ensures accuracy for both manufacturers and HTA bodies.